Lille, France

Pierre-Eloi Bontinck

This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Macopharma. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre-Eloi Bontinck. Retrieved from https://idiyas.com/inventor/pierre-eloi-bontinck-blcfkc39

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pierre-Eloi Bontinck: Innovator in Fluid Modification Technology

Introduction

Pierre-Eloi Bontinck is a notable inventor based in Lille, France. He has made significant contributions to the field of fluid modification through his innovative patent. His work focuses on enhancing the properties of fluids using advanced irradiation techniques.

Latest Patents

Pierre-Eloi Bontinck holds a patent titled "Method for modifying the properties of a fluid by irradiation, and system for implementing same." This patent outlines methods for altering the physical, chemical, and biological properties of a fluid through irradiation. The process involves supplying a flow of fluid to an irradiation chamber, focusing the flow to create fluid layers, and applying radiation to modify the properties of these layers.

Career Highlights

Bontinck is associated with Macopharma, a company dedicated to developing innovative medical solutions. His work at Macopharma emphasizes the application of his patented methods in real-world scenarios, contributing to advancements in medical technology.

Collaborations

Pierre-Eloi Bontinck has collaborated with notable colleagues, including Frédéric Deverre and Arnaud Chavatte. These collaborations have fostered a creative environment that enhances the development of innovative solutions in fluid modification.

Conclusion

Pierre-Eloi Bontinck's contributions to fluid modification technology through his patent demonstrate his commitment to innovation. His work at Macopharma and collaborations with esteemed colleagues further highlight his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…